This month, I had the privilege of joining fellow vision correction specialists at the EVO ICL User Summit, hosted by STAAR Surgical UK & Ireland. It was an inspiring event that brought together leaders in the field of refractive surgery to share experiences, discuss new frontiers, and explore the evolving role of implantable lenses in modern eye care.
The biggest takeaway? EVO ICL is changing the game — not just for patients with high prescriptions, but also for those with low myopia and hyperopia. For the first time, we’re able to offer lens-based vision correction safely and confidently to a broader group of people — including many who previously weren’t suitable for laser eye surgery.
What Makes EVO ICL So Different?
What impressed me most is the level of engineering behind each lens. The EVO ICL is crafted from Collamer®, a breakthrough material made from collagen and polymer. It’s soft, flexible, and biocompatible — meaning it works naturally with the human eye. Once implanted behind the iris, it becomes invisible to the outside world while delivering sharp, high-definition vision.
And with CentraFLOW™ Technology, the lens allows natural fluid movement within the eye, eliminating the need for additional surgical steps and ensuring a smoother, safer procedure.
What This Means for My Patients
At my London and Cheltenham clinic, I’m excited to now offer EVO ICL as a first-choice solution for a wide range of prescriptions. Whether you have thin corneas, dry eyes, or simply want a reversible alternative to LASIK, this lens gives you options — and control over your future vision.
Attending the summit has only strengthened my confidence in this platform and reaffirmed my commitment to giving patients access to the best that modern vision correction has to offer.
A Lens for the Future
EVO ICL isn’t just a treatment — it’s a future-proof solution. And I’m proud to offer it to my patients, backed by the training, precision, and expertise that define everything we do at my clinic.